Further, it has been found that PLT inhibited the invasion of DU-145 prostate cancer cells, which was accompanied by reduced transcriptional activity of NF-κB and subsequently its downstream target gene c-FLIP [24]. The gene discussed is CFLAR; the disease is prostate carcinoma.